Archivio Categoria: series C

Gauss Raises $20M in Series C

Gauss Surgical 334 State St., Ste. 201Los Altos, CA 94022650 949 4153http://www.gausssurgical.com/ Key contact Name Title Siddarth Satish CEO LOS ALTOS, CA, Gauss Surgical, an AI-driven healthcare technology company, raised $20 million in Series C funding. Gauss Surgical, an AI-driven healthcare technology company, raised $20 million in Series C funding from Northwell Health and SoftBank […]

Allbirds Nets $50M Series C

Allbirds 27-99 Hotaling PlSan Francisco, CA 94111888-963-8944http://www.allbirds.com/ Key contact Name Title Tim Brown Co-Founder SAN FRANCISCO, CA, Allbirds, has closed Series C funding of $50 million led by T. Rowe Price Investment Management. Today, Allbirds, the certified B-Corp brand pioneering the use of premium sustainable materials in footwear, announced that it has closed Series C […]

G2 Crowd Collects $55M in Series C

G2 Crowd 1910 1st Street Suite 400Highland Park, IL 60035847-748-7559www.g2crowd.com Key contact Name Title Godard Abel Co-Founder CHIACAGO, IL, G2 Crowd has announced its $55 million Series C funding round. FROM COMPANY WEB SITE: We're excited to announce our $55 million Series C funding round led by IVP, with participation from Emergence Capital, as well […]

RedShelf Receives $25M

RedShelf 215 W. Superior, Suite 600Chicago, IL 60654312-878-8586https://www.redshelf.com/ Key contact Name Title Greg Fenton CEO CHICAGO, IL, RedShelf, a leading distributor of digital course materials in higher education, today announced the closing of a $25 million Series C financing. The round was led by an entity advised by DNS Capital (DNS). The new financing will […]

Rgenix Grabs $40M Series C Financing

RGenix 310 East 67th Street, Suite 1-12�New York, NY 10065646-856-9261http://www.regenix.com/ Key contact Name Title Masoud Tavazoie CEO NEW YORK, NY, Rgenix announced that it has raised $40 million in a Series C financing. Rgenix, a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced that it has raised $40 million in […]

Brex Bags $125M in Series C

Brex San Francisco, CA833-228-2044https://brex.com/ Key contact Name Title Henrique Dubugras CEO SAN FRANCISCO, CA, First corporate card for startups, has closed a $125 million Series C funding round led by Greenoaks Capital and DST Global. Brex, the first corporate card for startups, announced today the close of a $125 million Series C funding round led […]

OmniSci Grabs $55M Series C Round

OmniSci 1 Front Street, Suite 2650San Francisco, CA 94111415-851-4787https://www.omnisci.com/ Key contact Name Title Todd Mostak CEO SAN FRANCISCO, CA, OmniSci (formerly MapD), the creator of an extreme analytics platform, today announced the completion of a $55 million Series C financing. The round was led by new investor Tiger Global Management. This round takes total funding […]

ExecOnline Nabs $18M Series C

ExecOnline 261 Madison Avenue, 9th FloorNew York, NY 10016800-410-EXEChttp://www.execonline.com/ Key contact Name Title Stephen Bailey CEO NEW YORK, NY, ExecOnline today announced it had closed an $18 million Series C funding. ExecOnline (EXO), a leader in delivering certificate-bearing leadership and development (L&D) programs in partnership with elite business schools, today announced it had closed an […]

MTPV Power Corporation Inks $16M

MTPV 13915 Burnet Road, Suite 420Austin, TX 78728512-246-1988www.mtpv.com Key contact Name Title Bob DiMatteo CEO AUSTIN, TX, MTPV Power Corporation, a clean energy company that converts heat to electricity using semiconductor chips, announced today that it raised $16 million in a Series C financing. The financing was led by Lake Bridge Capital, an early stage […]

KSQ Therapeutics Secures $80M Financing

KSQ Therapeutics 610 Main Street North, 4th FloorCambridge, MA 02139617-674-9150http://ksqtx.com/ Key contact Name Title David Meeker CEO CAMBRIDGE, MA, KSQ Therapeutics announced today that the company has secured an $80 million Series C financing. KSQ Therapeutics announced today that the company has secured an $80 million Series C financing to advance oncology drug candidates generated […]